Suppressive Effects of E3330, a Novel Quinone Derivative, on Tumor Necrosis Factor-alpha Generation from Monocytes and Macrophages

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1992 Nov 1

PMID 1284192

Citations 7

Authors

K Miyamoto

J Nagakawa

I Hishinuma

K Hirota

M Yasuda

T Yamanaka

K Katayama

I Yamatsu

Affiliations

Soon will be listed here.

Abstract

E3330 [(2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2- propenoic acid], a novel synthesized hepatoprotective compound, has suppressive effects on tumor necrosis factor-alpha (TNF-alpha) generation from monocytes/macrophages in vitro. E3330 (1-100 microM) reduced lipopolysaccharide (LPS, 10 mg/ml or 1 microgram/ml)-induced TNF-alpha generation from rat resident and Propionibacterium acnes (P. acnes)-elicited peritoneal macrophages, rat and human monocytes, rat Kupffer cells, and splenic mononuclear cells in a concentration-dependent manner. E3330 also (1-100 microM) suppressed TNF-alpha generation stimulated with egg-albumin immune complex in rat P. acnes-elicited peritoneal macrophages. Northern blot analysis showed that LPS-induced expression of TNF-alpha messenger RNA (mRNA) in human blood monocytes was suppressed by E3330. These findings indicate that E3330 has a suppressive effect on TNF-alpha generation from monocytes/macrophages, regardless of origin or species, and this effect is based in part on the suppression of TNF-alpha mRNA expression.

Citing Articles

APE1/Ref-1 Role in Inflammation and Immune Response.

Oliveira T, Coutinho L, de Oliveira L, de Souza Timoteo A, Farias G, Agnez-Lima L Front Immunol. 2022; 13:793096.

PMID: 35296074 PMC: 8918667. DOI: 10.3389/fimmu.2022.793096.

Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.

Srinivasan A, Wang L, Cline C, Xie Z, Sobol R, Xie X Biochemistry. 2012; 51(31):6246-59.

PMID: 22788932 PMC: 3448856. DOI: 10.1021/bi300490r.

Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages.

Jedinak A, Dudhgaonkar S, Kelley M, Sliva D Anticancer Res. 2011; 31(2):379-85.

PMID: 21378315 PMC: 3256557.

Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1.

Kelley M, Luo M, Reed A, Su D, Delaplane S, Borch R Antioxid Redox Signal. 2010; 14(8):1387-401.

PMID: 20874257 PMC: 3061197. DOI: 10.1089/ars.2010.3410.

The many functions of APE1/Ref-1: not only a DNA repair enzyme.

Tell G, Quadrifoglio F, Tiribelli C, Kelley M Antioxid Redox Signal. 2008; 11(3):601-20.

PMID: 18976116 PMC: 2811080. DOI: 10.1089/ars.2008.2194.

References

Vitti G, Hamilton J . Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid. Arthritis Rheum. 1988; 31(8):1046-51. DOI: 10.1002/art.1780310817. View

Schwartz R, Haron J, Rothblum K, Dugaiczyk A . Regulation of muscle differentiation: cloning of sequences from alpha-actin messenger ribonucleic acid. Biochemistry. 1980; 19(25):5883-90. DOI: 10.1021/bi00566a034. View

Beutler B, Krochin N, Milsark I, Luedke C, Cerami A . Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986; 232(4753):977-80. DOI: 10.1126/science.3754653. View

Knook D, Sleyster E . Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res. 1976; 99(2):444-9. DOI: 10.1016/0014-4827(76)90605-4. View

Yamazaki S, Onishi E, Enami K, Natori K, Kohase M, Sakamoto H . Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Jpn J Med Sci Biol. 1986; 39(3):105-18. DOI: 10.7883/yoken1952.39.105. View

Nagakawa J, Hishinuma I, Hirota K, Miyamoto K, Yamanaka T, Tsukidate K . Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology. 1990; 99(3):758-65. DOI: 10.1016/0016-5085(90)90965-4. View

Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

Kunkel S, Spengler M, May M, Spengler R, Larrick J, Remick D . Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988; 263(11):5380-4. View

McClain C, Cohen D . Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989; 9(3):349-51. DOI: 10.1002/hep.1840090302. View

10.

Kobayashi Y, Asada M, Higuchi M, Osawa T . Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor. J Immunol. 1982; 128(6):2714-8. View

11.

Decker T, Lohmann-Matthes M, Gifford G . Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol. 1987; 138(3):957-62. View

12.

Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M . Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 1989; 10(5):769-73. DOI: 10.1002/hep.1840100504. View

13.

GLISIN V, Crkvenjakov R, Byus C . Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974; 13(12):2633-7. DOI: 10.1021/bi00709a025. View

14.

Gemsa D, Kramer W, Napierski I, Barlin E, TILL G, Resch K . Potentiation of macrophage tumor cytostasis by tumor-induced ascites. J Immunol. 1981; 126(6):2143-50. View

15.

Nagakawa J, Hishinuma I, Miyamoto K, Hirota K, Abe S, Yamanaka T . Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice. J Pharmacol Exp Ther. 1992; 262(1):145-50. View

16.

Goeddel D, Aggarwal B, Gray P, Leung D, Nedwin G, Palladino M . Tumor necrosis factors: gene structure and biological activities. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 1:597-609. DOI: 10.1101/sqb.1986.051.01.072. View

17.

Aggarwal B, Kohr W, Hass P, Moffat B, Spencer S, Henzel W . Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985; 260(4):2345-54. View

18.

Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T . Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology. 1990; 12(5):1187-91. DOI: 10.1002/hep.1840120518. View

19.

Kelker H, Oppenheim J, Aggarwal B, Stevenson H, Vilcek J . Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. Int J Cancer. 1985; 36(1):69-73. DOI: 10.1002/ijc.2910360112. View

20.

Tiegs G, Wolter M, Wendel A . Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1989; 38(4):627-31. DOI: 10.1016/0006-2952(89)90208-6. View